Research graph

References

References from Autoimmune-Mediated Hypertriglyceridemia in a Young Male with Refractory Immune Thrombocytopenia: A Case Report. Local targets link to admitted publications; unresolved targets remain external evidence.

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

10.1016/j.cmet.2007.02.002 · 2007 · External reference

Chylomicronemia from GPIHBP1 autoantibodies

10.1194/jlr.r120001116 · 2020 · External reference

Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia

10.1056/nejmoa1611930 · 2017 · External reference

Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia

10.5551/jat.63348 · 2023 · External reference

Clinical review on triglycerides

10.1093/eurheartj/ehz785 · 2020 · External reference

Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650)

10.1186/1476-511x-6-23 · 2007 · External reference

Chylomicronaemia--current diagnosis and future therapies

10.1038/nrendo.2015.26 · 2015 · External reference

Unresolved reference

External reference

Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target

10.1007/s11883-026-01399-y · 2026 · External reference

The evaluation of plozasiran for the treatment of familial chylomicronemia syndrome

10.1080/17446651.2026.2646166 · 2026 · External reference

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

10.1056/nejmoa1715944 · 2019 · External reference

Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk

10.1056/nejmoa2409368 · 2025 · External reference